earnings
KA
NASDAQ · KALV
KalVista Pharmaceuticals, Inc.
Healthcare · Biotechnology
$27.00
Up+$0.00 (+0.00%)
Updated Sep 16, 2026, 5:17 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 854.23M
- P/E ratio
- -4.45
- Dividend yield
- 0.00%
- 52-week range
- $9.83 – $27.00
- Volume
- 4.27M
- Avg. volume
- 1.41M
Price performance
KALV price history
1M range · 0 trading sessions · Daily adjusted prices
KALV does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest KALV news
The latest Smart Investors Daily articles mentioning KALV.
Stock researchResearch & News · SID Coverage
Loading stock research…